Viewing StudyNCT02304393



Ignite Creation Date: 2024-05-06 @ 3:30 AM
Last Modification Date: 2024-10-26 @ 11:34 AM
Study NCT ID: NCT02304393
Status: COMPLETED
Last Update Posted: 2019-12-13
First Post: 2014-11-26

Brief Title: A Study of Selicrelumab RO7009789 in Combination With Atezolizumab in Participants With Locally Advanced andor Metastatic Solid Tumors
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche

Conditions & Keywords Data

Conditions:
Name
Solid Tumors
Keywords: